CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection by Schaefer, Arne S. et al.
CDKN2BAS is associated with periodontitis in
different European populations and is activated by
bacterial infection
Arne S Schaefer,1 Gesa M Richter,1 Henrik Dommisch,2 Markus Reinartz,2
Michael Nothnagel,3 Barbara Noack,4 Marja L Laine,5 Mathias Folwaczny,6
Birte Groessner-Schreiber,7 Bruno G Loos,5 Søren Jepsen,2 Stefan Schreiber1
ABSTRACT
Epidemiological studies have indicated a relationship
between coronary heart disease (CHD) and periodontitis.
Recently, CDKN2BAS was reported as a shared genetic
risk factor of CHD and aggressive periodontitis (AgP), but
the causative variant has remained unknown. To identify
and validate risk variants in different European
populations, we first explored 150 kb of the genetic
region of CDKN2BAS including the adjacent genes
CDKN2A and CDKN2B, covering 51 tagging single
nucleotide polymorphisms (tagSNPs) in AgP and chronic
periodontitis (CP) in individuals of Dutch origin (n¼313).
In a second step, we tested the significant SNP
associations in an independent AgP and CP population of
German origin (n¼1264). For the tagSNPs rs1360590,
rs3217992, and rs518394, we could validate the
associations with AgP before and after adjustment for
the covariates smoking, gender and diabetes, with SNP
rs3217992 being the most significant (OR 1.48, 95% CI
1.19 to 1.85; p¼0.0004). We further showed in vivo
gene expression of CDKN2BAS, CDKN2A, CDKN2B, and
CDK4 in healthy and inflamed gingival epithelium (GE)
and connective tissue (CT), and detected a significantly
higher expression of CDKN2BAS in healthy CT compared
to GE (p¼0.004). After 24 h of stimulation with
Porphyromonas gingivalis in Streptococcus gordonii pre-
treated gingival fibroblast (HGF) and cultured gingival
epithelial cells (GECs), we observed a 25-fold and
fourfold increase of CDKN2BAS gene expression in HGFs
(p¼0.003) and GECs (p¼0.004), respectively.
Considering the global importance of CDKN2BAS in the
disease risk of CHD, this observation supports the theory
of inflammatory components in the disease physiology of
CHD.
INTRODUCTION
Coronary heart disease (CHD) is the leading cause
of death worldwide1 2 and is considered to be
a complex multifactorial disease. Epidemiological
studies have shown a significant correlation
between periodontal health and the occurrence of
cardiovascular events.3 4 Periodontitis and CHD are
both strongly promoted by very similar environ-
mental and behavioural risk factors, with smoking
and diabetes being the most prominent.5e13
Furthermore, the same pathogenic bacterial strains
were observed in both inflamed gingival tissue and
atherosclerotic plaques.10 14 15 It has also been
shown that periodontal treatment results in
improvement of endothelial function, a marker for
risk prediction of cardiovascular events.16 Recently,
a major genetic susceptibility locus for CHD was
identified by various genome wide association
studies (GWAS).17e20 This locus is located within
the chromosomal region 9p21.3, mapping to the
large non-coding (nc) antisense RNA transcript
CDKN2BAS, formerly called ANRIL. This associa-
tion was verified by a subsequent meta-analysis9
and by a large scale replication study,21 making this
genetic region the best replicated CHD associated
risk locus to date. In addition, variants within this
region were independently found to be associated
with type 2 diabetes,22e24 abdominal aortic and
intracranial aneurysms,25 ischaemic stroke,26
Alzheimer ’s disease and vascular dementia,27 and
high grade glioma susceptibility.28 Recently, we
demonstrated the association of a highly increased
risk for aggressive periodontitis (AgP) with specific
variants of CDKN2BAS.29 However, despite exten-
sive fine mapping and functional studies, the
causative variant and the functional role of
CDKNBAS has remained unknown.9 30 In recent
years, long non-coding RNAs like CDKN2BAS have
been recognised for their role in regulating gene
expression by contributing to the recruitment of
protein complexes to target genes in trans, and to
provide an architectural matrix to retain the
proteins at the repression site of the target gene.
Unprecedented, a role in cis regulation of CDKN2A
expression was very recently described for a new
transcript of CDKN2BAS that initiates upstream of
the previously reported start site,31 indicating
a regulatory role for CDKN2BAS in the context of
cellular proliferation.
In the present study, we aimed to identify
genetic risk variants of CDKN2BAS that are shared
by different European caseecontrol populations of
aggressive and chronic periodontitis. To this end,
we covered >150 kb with 51 tagging single nucle-
otide polymorphisms (tagSNPs) mapping to
CDKN2BAS and the adjacent cell cycle inhibitor
genes CDKN2A and CDKN2B. We explored the
SNP associations in two populations of AgP and
chronic periodontitis (CP) of Dutch origin (n¼313),
and replicated the significant associations in two
populations of AgP and CP of German origin
(n¼1264).
Recently, differential gene expression of
CDKN2BAS in a variety of CHD relevant tissues,
such as vascular endothelial cells, smooth coronary
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muscle cells, fibroblasts, and macrophages, has been demon-
strated.30 32 33 To study the tissue specific expression in the
gingiva, we quantified the mRNA transcription pattern of
CDKN2BAS, CDKN2A and CDKN2B in healthy and inflamed
human gingival tissue samples. Additionally, we studied the
gingival expression of CDK4, a cell cycle regulating kinase that is
directly inhibited by CDKN2A and CDKN2B. To explore the
possibility that both periodontitis and CHD share an inflam-
matory pathophysiology, we assessed the potential role of
pathogenic bacteria in the transcriptional regulation of these
genes in different gingival tissues.
PATIENTS AND METHODS
Study population
The patient and control samples of the CP and AgP association
studies were recruited across Germany and the Netherlands as
previously described.34 Only individuals of German and Dutch
ethnicity were included, judged upon the location of both
parental birthplaces. Before the study, the genetic sub-structure
of the German and Dutch populations had been assessed,35 36
indicating only negligible sub-structures and therefore allowing
an analysis of the German and Dutch individuals in a single
genetic study without the risk of substantial population strati-
fication. A detailed description of the study population is given
in table 1 and in the supplementary information. Informed
written consent was obtained from all subjects recruited into
this study. The study was approved by each institute’s own
ethical review board (Medical Ethical Committee, Universities
of Bonn, Dresden, Kiel and Munich, and Medical Ethical
Committee, Academic Medical Center, University of
Amsterdam, The Netherlands).
DNA extraction and genotyping
Genomic DNA was extracted from blood (Invisorb Blood
Universal Kit, Invitek, Berlin, Germany) or mouthwash
samples,37 and was amplified by whole genome amplification
(GenomiPhi, Amersham, Uppsala, Sweden). TagSNPs were
selected from the CEU data of the International HapMap project
(http://www.hapmap.org, NCBI build 36, 2008-03) using the
Tagger feature38 of Haploview 4.0.39 TagSNPs were defined by
pair-wise linkage disequilibrium tagging (r2 >0.8). Genotyping
was carried out using the SNPlex and TaqMan Genotyping
System (Applied Biosystems, Foster City, California, USA) on an
automated platform, using TECAN Freedom EVO and 96-well
and 384-well TEMO liquid handling robots (TECAN, Männe-
dorf, Switzerland). Genotypes were generated by automatic
calling using the Genemapper 4.0 software (Applied Biosystems)
with the following settings: 2 separation >6, angle separation
for two cluster SNPs <1.2 rad, median cluster intensity >2.2
logs. Genotypes were further reviewed manually and call rates
$90% in each sample set were required.
Gingival tissue samples and cell culture
For gene expression study, gingival tissue samples were obtained
from individuals with healthy gingival conditions and no
periodontitis (n¼10) as well as from patients with advanced CP
(n¼10). All biopsies were collected from healthy patients (age
19e58 years) who underwent third-molar extraction or peri-
odontal surgery and from patients with advanced CP. Healthy
gingival conditions were defined as follows: no redness, no
swelling, no bleeding on probing, and with periodontal pockets
#3 mm. Patients with advanced CP showed all typical clinical
signs of periodontal inflammation (redness, swelling, bleeding on
probing) and a periodontal probing depth $6 mm. For culture of
gingival epithelial cells (GECs) (n¼3) and human gingival
fibroblasts (HGFs) (n¼3), gingival epithelial tissue samples were
prepared as previously described.40 Epithelial cells were cultured
in keratinocyte growth medium (KGM) using supplements
provided with the medium (PAA, Cölbe, Germany) and 1%
antibiotics (penicillin, streptomycin, amphotericin; PAA),
whereas fibroblasts were cultured using Dulbecco’s modified
Eagle’s medium (DMEM; PAA) supplemented with 1% antibi-
otics (penicillin, streptomycin, amphotericin; PAA) and 10%
fetal bovine serum (FBS; PAA). Both GECs and HGFs were
cultured at 378C in a humidified atmosphere (5% carbon
dioxide).
Bacterial cell culture and stimulation experiments
Wild-type Porphyromonas gingivalis strain ATCC 33277 was
cultured under anaerobic conditions, whereas Streptococcus
gordonii was grown under aerobic conditions as previously
described.41 42 Bacterial numbers were determined by absorbance
measurement using a spectrophotometer (Biochrom AG, Berlin,
Germany). To mimic early stages of inflammation and to test











Individuals, N (%) 159 154 421 301 740 962
Men 41 (25.8) 56 (36.4) 185 (43.9)
5 ns




Women 118 (74.2) 98 (63.6) 231 (54.9) 189 (62.8) 433 (58.5) 402 (41.8)
Mean age (SD) at first diagnosis 30.4 (4.2) ns e 29.5 (4.7) ns e
Mean age (SD) at examination 33.8 (4.7) 45.2 (9.5) 32.3 (9.0) 31.4 (6.1) 61.2 (10.3) 56.9 (12.7)
Study information
Recruitment period 2003e2008 1995e2004 1995e2008 2003e2008 2000e2006 2002e2006
Phenotype
Affected teeth, mean (SD) 5.8 (3.9) ns e 8.6 (6.4) ns e
Risk factor, N (%)




















Values are given as mean (SD) when appropriate. Affection status was based on reported history. Age was reported by the clinicians. Smoking was estimated by self-report of the individuals.
ns, not specified.
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the potential transcriptional response of these genes, the
commensal oral bacterium S gordonii and the pathogenic oral
bacterium P gingivalis, commonly present during severe peri-
odontal infection, were chosen to create an in vitro model to
mimic periodontal infection of GECs and HGFs. For stimulation
experiments, GECs and HGFs were grown to 80% confluence
and then incubated with P gingivalis and S gordonii, respectively,
using an amount equivalent to a multiplicity of infection of
100:1, for either 6 h or 24 h. Experimental groups were: (1)
unstimlated GECs and HGFs; (2) control cells (GECs and HGFs)
treated with blank bacterial medium for S gordonii not
containing bacterial cells; (3) control cells (GECs and HGFs)
treated with blank bacterial medium for P gingivalis not
containing bacterial cells; (4) stimulation of GECs and HGFs
with S gordonii; (5) stimulation of GECs and HGFs with
P gingivalis; and (6) pre-incubation of GECs and HGFs with
S gordonii followed by medium change and stimulation with
P gingivalis. Each stimulation experiment was performed in
triplicate, using cells from three different donors.
RNA extraction and PCR conditions
To extract mRNA from the epithelial and the connective tissue
layer separately, biopsies were enzymatically dissected using
3 ml dispase (Cascade Biologics, Paisley, UK) for 6 h on ice. After
separation of gingival biopsies, total RNA was extracted from
both epithelium and connective tissue (CT) using the RNeasy
Protection Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer ’s instructions.
Subsequent to in vitro stimulation experiments on GECs and
HGFs, total RNA was extracted as described above. The reverse
transcription reaction with 500 ng of total RNA was performed
using iScript (Bio-Rad, Munich, Germany) following the
manufacturer ’s instructions.
Quantitative analysis of the cDNA was performed using the
iCycler (Bio-Rad) and the QuantiFast SYBR Green PCR kit
(Qiagen) according to the manufacturer ’s instructions. PCR
reactions were carried out in 96-well plates in a total volume of
25 ml, including 10 ng of cDNA and 250 nM primers. At the end
of each real-time PCR, melting curve analysis was performed to
confirm that the amplified product was specific. Gene expression
levels in the gingival epithelium and the gingival connective
tissue were analysed by normalisation to the gene expression
levels in healthy gingival epithelium. All sample values were
normalised to the expression of the housekeeping gene glycer-
ylaldehyde-3-dehydrogenase (GAPDH, GeneGlobe primer,
Qiagen) and relative gene expression was calculated using the
delta-delta Ct (threshold cycle) method. PCR controls were
performed using water. Primer sequences are given in
supplementary table 1.
Statistical analysis
Markers were checked for deviation from HardyeWeinberg
equilibrium (HWE) in controls to a significance level of a¼0.05
before inclusion into the analysis. We assessed the significance of
phenotypic association with single marker alleles and genotypes
using c2 and Fisher ’s exact tests for 232 and 233 contingency
tables, respectively. Logistic regression analysis allowing for
covariate adjustment was performed in the R statistical envi-
ronment, version 2.8.1.43 Significance was assessed by a likeli-
hood ratio test. Values of p#0.05 were considered nominally
significant. Akaike’s information criterion (AIC) was used to
choose the model that best explained the underlying associa-
tions. Linkage disequilibrium (LD) measures were calculated
and plotted using Haploview. Quantitative real time (qRT)-PCR
(qRT-PCR) data were analysed using the ManneWhitney Test
(SPSS, Version 18, Munich, Germany). The significance level was
set at p#0.05.
RESULTS
Association study with aggressive periodontitis
To analyse potential genetic associations within the entire
CDKN2BAS region, we selected 51 tagSNPs covering 150 kb.
These SNPs were genotyped in our combined population of 159
Dutch generalised and localised AgP patients and 421 Dutch
healthy controls. In our previous study on the association of
CDKN2BAS with AgP,29 we demonstrated that the allele
frequencies at this genetic locus were very similar between
localised and generalised AgP cases, allowing the pooling of both
sub-phenotypes to increase the statistical power for detecting
associated variants. In a second step, we validated the significant
SNPs in an independent panel of our 301 German patients with
generalised or localised AgP and 963 German controls.29 In
a third step, we subsequently tested the selected tagSNPs in this
genetic region for potential associations with chronic perio-
dontitis in a panel of 154 Dutch CP cases, and replicated the
significant associations in an independent panel of 740 German
CP cases. To increase the statistical power, we used the same
panels of Dutch and German controls for the association tests
performed with the Dutch and German AgP and CP patients,
respectively (table 1).
Out of the 51 tagSNPs, eight were found to have a minor
allele frequency (MAF) below 0.01 in the Dutch populations.
These were excluded from the analysis due to their limited
expected statistical power. Five further SNPs were excluded due
to deviations from HWE in the Dutch controls (p<0.05). One
SNP, rs564398, had poor genotyping quality (call rate <0.9) and
was excluded from further analyses. In the explorative associa-
tion study of the Dutch AgP caseecontrol population, four SNPs
were nominally significantly associated with AgP before
adjustment for the common risk factors of gender, smoking, and
diabetes (supplementary table 2). Upon covariate adjustment,
seven SNPs were nominally significantly associated (table 2, for
genotype and allele frequencies see table 3), with SNP rs3217992
being the most significant (OR 2.53, 95% CI 1.29 to 5.13;
p¼0.007). Two SNPs, rs1360590 and rs11790231, showed asso-
ciations before and after covariate adjustment (supplementary
tables 2 and 3).
These seven nominally significantly associated SNPs were
then tested for their association in the German AgP population.
One SNP, rs10965224, showed significant deviations from HWE
in the German controls (p<0.05) and was excluded from further
analyses. Before the covariate adjustment, three of the associa-
tions remained significant (rs3217992, rs518394, rs1360590),
with SNP rs1360590 being most significantly associated with
p¼0.0005 (multiplicative genetic model) and an OR of 1.41 (CI
95% 1.16 to 1.72) (supplementary table 4). Upon covariate
adjustment, these three SNPs remained significantly associated,
with rs3217992 being most significant with p¼0.0004 (table 2,
supplementary table 5) and an OR of 1.48 (95% CI 1.19 to 1.85).
After Bonferroni correction for multiple testing, these three
SNPs remained significant at the corrected significance threshold
of p#0.0083 for six independent tests. These three SNPs span
a chromosomal region of 38 kb (NCBI build 36.3) and are located
within (rs3217992) or downstream of CDKN2B, but were only
in moderate LD to each other in our control population
(figure 1). Interestingly, none of the SNPs which tagged the large
LD region at the 59 end of CDKN2BAS, and which was most
significantly associated with CHD 9 17e19 20 as well as with AgP
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in our German cases,29 was significantly associated with the
Dutch AgP patients in this study. The lead SNPs of this region
were associated with CHD and the German AgP cases with
a 10% increase of the rare allele in the homozygotes (eg for SNP
rs1333048) and showed similar allele frequencies for the
heterozygotes between cases and controls. In contrast, for
the Dutch AgP cases we observed an enrichment of 10% in the
heterozygotes but a decrease of 6% of the rare allele in the
homozygotes (supplementary table 6).
Association study with chronic periodontitis
In the next step, we tested the 37 tagSNPs that had passed the
pre-assigned QC for their association with the phenotype
chronic periodontitis in the explorative Dutch CP population.
Five SNPs were significant before covariate adjustment for
gender, age, smoking, and diabetes, with SNP rs10965238 being
the most significant (OR 0.57, 95% CI 0.38 to 0.84; p¼0.004)
(supplementary table 7). Upon adjustment, four SNPs remained
significant (rs1360590, rs10965224, rs10965238, rs10811658),
two of which showed stable associations before and upon
covariate adjustment (rs10965238, rs10811658) (figure 1, table 2
and supplementary table 8).
We next tested these three SNPs for their association in the
German CP population, again excluding SNP rs10965224 due to
its significant deviations from HWE in this control population.
Before covariate adjustment, SNP rs10811658 was significantly
associated with CP (supplementary table 9). Upon adjustment,
this association remained significant in a similar fashion with
p¼0.025 (OR 0.66, 95% CI 0.46 to 0.95) (table 2). However, after
Bonferroni correction for multiple testing, this association
missed significance at the corrected significant threshold of
p<0.0167 for three independent tests. None of the other SNPs
tested in this caseecontrol population showed significant asso-
ciations upon covariate adjustment (supplementary table 10).
CDKN2BAS, CDKN2A, CDKN2B, and CDK4 mRNA expression in
healthy and inflamed gingival tissues
To show in vivo gene expression of CDKN2BAS, CDKN2A,
CDKN2B, and CDK4, the specific mRNA levels of these genes
within the epithelium (EPI) and the connective tissue (CT) of
gingival biopsies were analysed. We observed tissue specific
expression of all four genes in both EPI and CT. In this explor-
ative study, the expression of CDKN2BAS was significantly
higher in healthyCTcompared to healthy EPI (p¼0.004,figure 2A),
and this difference remained significant after Bonferroni correction
for multiple comparisons. Whereas for CDKN2A no difference in
transcript levels was observed between CT and EPI (figure 2B),
higher mRNA levels, although not significant in our experiments,
were observed forCDKN2B in healthyCTcompared to healthy EPI
(p¼0.019, figure 2C). A trend towards a lower gene expression for
CDK4, inhibited by CDKN2A and 2B in vivo, was noticed in CT
compared to EPI (figure 2D).
CDKN2BAS gene expression upregulated in S gordonii
pre-treated and P gingivalis stimulated GECs
We next tested whether the genes were differentially regulated
in cultured primary gingival epithelial cells (GECs) when
exposed to commensal and/or pathogenic periodontal bacteria.
We observed a significant increase of the CDKN2BAS gene
expression after 24 h of stimulation with pathogenic P gingivalis
Table 2 Minor allele frequencies (MAFs) and single nucleotide polymorphism (SNP) associations of the significant SNPs in the different populations
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Given are the MAFs, the p values, and the ORs with the 95% CIs for the different populations. The p values were obtained from a likelihood ratio test and correspond to the genetic model with
the lowest AIC value each. Values are given upon adjustment for the covariates smoking, diabetes, and gender for the aggressive periodontitis (AgP) analyses and additionally for age for the
chronic periodontitis (CP) analyses, in a logistic regression model.
Table 3 Genotypes and frequencies of the significant single nucleotide polymorphisms (SNPs) in the different populations
Dutch controls German controls
Dutch aggressive
periodontitis (AgP) German AgP
Dutch chronic
periodontitis (CP) German CP
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in commensal S gordonii pre-treated GECs with p¼0.003 (four-
fold increase), and this difference remained significant after
Bonferroni correction for multiple comparisons (figure 3A). In
the same experiments, CDKN2A mRNA levels were significantly
reduced after 24 h of stimulation with pathogenic P gingivalis in
commensal S gordonii pre-treated GECs with p¼0.004, if
compared to unstimulated GECs (figure 3B). A similar reduction,
not significant in our experiments, was observed between 6 h
and 24 h of P gingivalis stimulation after S gordonii pre-treat-
ment. For CDKN2B, we observed a trend towards reduced
Figure 1 Genetic region of CDKN2BAS, The top diagram shows the nominal elog10 p under the assumption of the different genetic models of those
single nucleotide polymorphisms (SNPs) that passed the preassigned quality criteria. The elog10 p values are plotted as a function of the genomic
htSNP position (NCBI build 36). The bottom panel shows pairwise linkage disequilibrium (LD) in the controls using metric r2. AgP, aggressive
periodontitis; CP, chronic periodontitis; Dominant, dominant model; Genotypic, genotypic model; Ger, Germany; NL, Netherlands; Recessive, recessive
model; bp, base pairs; 1, rs3731257; 2, rs3731239; 3, rs2811709; 4, rs7036656; 5, rs3218009; 6, rs3217992; 7, rs3217986; 8, rs495490; 9, rs518394;
10, rs1360590; 11, rs17694493; 12, rs11790231; 13, rs1011970; 14, rs10965224; 15, rs16905599; 16, rs10757270; 17, rs1412832; 18, rs10965227;
19, rs10965228; 20, rs1333040; 21, rs2891168; 22, rs10125231; 23, rs1333042; 24, rs13301964; 25, rs1333045; 26, rs1333048; 27, rs1333049; 28,
rs1333050; 29, rs10757281; 30, rs10965238; 31, rs10811658; 32, rs12347779; 33, rs10965245; 34, rs2891169; 35, rs7045889; 36, rs10811661; 37,
rs10757283.
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transcript levels after 24 h incubation with P gingivalis in
S gordonii pre-treated GECs (figure 3C). CDK4 expression was
significantly reduced after 24 h of stimulation with pathogenic
P gingivalis in commensal S gordonii pre-treated GECs compared
to unstimulted GECs (p¼0.004, figure 3D). A similar reduction,
not significant in our experiments, was observed between 6 h
and 24 h P gingivalis stimulation after S gordonii pre-treatment.
CDKN2BAS gene expression upregulated in P gingivalis
stimulated HGFs
In the second gingival cell population of gingival fibroblasts
(HGFs), 24 h stimulation with P gingivalis alone and after pre-
treatment with S gordonii led to significant CDKN2BAS mRNA
upregulation after 24 h with p¼0.004 and p¼0.003 (25-fold),
respectively, and remained significant after Bonferroni correction
for multiple comparisons (figure 4A). CDKN2A mRNA levels
were significantly reduced (p¼0.001) after 24 h stimulation with
P gingivalis after pre-treatment with S gordonii (figure 4B). No
clear trend in transcript levels could be observed for CDKN2B
and CDK4 in any experimental condition (figure 4C,D).
DISCUSSION
The aim of this study was to identify genetic risk alleles within
the genetic region of CDKN2BAS, CDKN2A and CDKN2B,
which are shared by different European populations of the
periodontal disease phenotypes AgP and CP. We showed three
SNPs to be significantly associated with two AgP populations of
different ancestry (rs3217992, rs518394, and rs1360590), and
confirmed these associations to be independent of the traditional
risk factors of smoking, diabetes and gender. These SNPs were
located within or closely downstream of the coding region of
CDKN2B, but no SNP could be identified as a lead SNP that fully
explained the associations with periodontitis.
Interestingly, we could not replicate our previous finding of
a statistically significant association of the large CHD associated
LD region at the 59 end of CDKN2BAS with the Dutch AgP
patients. As described earlier,29 in the German AgP cases the
frequency of the rare allele of the lead SNP from this study,
rs1333048, was 10% higher compared to the controls and the
frequencies for the heterozygotes was similar to the controls.
This observation was similarly reported by association studies
on CHD.9 Interestingly, in the present study, the Dutch AgP
cases showed an enrichment of 10% in the heterozygotes for this
SNP, but the homozygotes of the risk allele were decreased. We
ruled out potential genotyping errors of this assay by verifying
the genotypes of SNP rs1333048 with two independent tech-
nologies, which gave identical results. Increased heterozygotes in
the Dutch AgP cases were similarly observed for the significantly
associated SNPs rs1360590, rs3217992, and rs518394. In contrast
to the observation in the Dutch AgP patients, the Dutch CP
cases, and to a lesser extent the German CP cases, showed
a tendency towards an increased frequency of homozygosity for
the risk allele, with a frequency of heterozygotes similar to the
controls. A possible speculative explanation for the observed
increase of heterozygous Dutch AgP patients at this particular
locus could be the presence of duplicated structural variations of
this element in these cases, which were not present in the Dutch
controls and CP cases.
The discovered associations, which were shared between
different populations, did not follow a particular model of
inheritance (genotypic, dominant, recessive or multiplicative).
However, this observation is rather typical for association
studies of our sample sizes, where it is practically impossible to
assess confidently which model fits the data best, and where
the specific models might reflect noise rather than a specific fit
to a model. A future meta-analysis with data across many
different datasets will improve this situation and might help to
identify the best-fit model.44 The genetic effects that were
estimated for the associated SNPs also partly differed between
the populations. Corresponding to the variations in the genetic
best-fit models, the genetic effects are statistical estimates
which are liable to estimation errors, which are mostly attrib-
uted to effects of individual random samples which constitute
Figure 2 mRNA levels of CDKN2BAS,
CDKN2A, CDKN2B and CDK4 in healthy
and inflamed gingival epithelium and
connective tissue. (A) CDKN2BAS
transcript levels were higher in healthy
connective tissue compared to healthy
gingival epithelium (p¼0.004). (BeD)
CDKN2A, CDKN2B, and CDK4 mRNA
showed no statistically significant
differences in transcript levels between
healthy or inflamed epithelial and
connective gingival tissues. Each box
plot represents results derived from 10
different subjects. CT, connective
tissue; EPI, gingival epithelial tissue;
H, healthy; I, inflamed.
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each population analysed. If the causative variant has not been
identified, the observed SNP associations reflect the genetic
effect of the causative variant through shared LD, which can
vary between populations of different ancestry.
Although this broad validation study of the previously
reported association of CDKN2BAS with periodontitis adds
further evidence that variants at this locus increase the risk of
periodontitis in individuals of Northern European origin, it is
evident from the number and distribution of the significant SNP
associationsdwhich were observed in our current and our
previous study, and similarly in other larger studies on CHD9 33d
that the causative variant(s) and the related disease mechanisms
remain to be identified. Additionally, we observed nominally
significant SNP associations in the CP populations. Considering
that individuals who experienced early development of perio-
dontitis are likely to have inherited a major genetic disease
variant, it is conceivable that in larger populations of
the rather moderate phenotype chronic periodontitis, these
SNPs may show their significance for CP as well as they did
for the more severe AgP phenotype. To clarify this, replication
experiments in further large populations of CP would be
desirable.
The risk of periodontitis related to this locus may vary
among different ethnic groups, which is suggested by frequency
variations of the disease associated rs1333048-C allele from 21%
in Yoruba to 51% in European and Japanese in HapMap. To
identify the true causative variant(s), that may also be different
between various ethnic groups, further genetic exploration of
this genetic region in much larger analysis populations,
including large analysis populations of various ethnic back-
grounds, is necessary. A technical limitation of our study was the
failure to genotype 16 of the selected tagSNPs in all populations,
especially when the moderate LD across most of the genetic
region of CDKN2BAS is considered. Here, an LD region
harbouring the potential true variant(s) might have been missed.
Future studies that will apply deep resequencing of cases
carrying the associated variants across CDKN2BAS will obtain
the full spectrum of variation in this region, and will be able to
identify the causal variant(s) that affect the genetic risk.
In the second part of our study, we analysed the expression
patterns of CDKN2BAS, CDKN2A, CDKN2B, and CDK4 in
healthy and inflamed gingiva, and assessed if these genes were
regulated by a signal transduction cascade sensitive to bacterial
infection. All analysed genes were expressed in the gingiva, with
CDKN2BAS and CDKN2B both showing the highest mRNA
levels of the analysed genes in CT. We did not observe different
transcript levels between healthy or inflamed gingival tissues.
This could indicate that these genes are not regulated by the
Figure 3 mRNA levels of CDKN2BAS,
CDKN2A, CDKN2B, and CDK4 in gingival
epidermal cells after stimulation with
Streptococcus gordonii and
Porphyromonas gingivalis. (A) After
24 h of bacterial infection, CDKN2BAS
mRNA expression was significantly
increased upon 24 h P gingivalis
stimulation of S gordonii pre-treated
gingival epithelial cells (GECs) compared
to 6 h of stimulation (p¼0.003). (B)
CDKN2A gene expression was
significantly reduced in response to 24 h
of P gingivalis stimulation after S
gordonii pre-treatment compared to
unstimulated GECs (p¼0.004). A similar
reduction, not significant in our
experiments, was observed between
6 h and 24 h of P gingivalis stimulation
after S gordonii pre-treatment. (C) For
CDKN2B, no significant differences in
mRNA transcript levels were observed
in GECs upon bacterial stimulation. (D)
CDK4 mRNA levels were significantly
reduced after S gordonii pre-treated
followed by 24 h of stimulation with P
gingivalis compared to unstimulated
GECs (p¼0.004). A similar reduction,
not significant in our experiments, was
observed between 6 h and 24 h of P
gingivalis stimulation after S gordonii
pre-treatment. Each box plot represents
values derived from nine independent
experiments and cells from three
different donors were tested. C,
unstimulated cells; GEC, gingival
epidermal cells; MPG, blank medium for
P gingivalis; MSG, blank medium for S
gordonii; PG, P gingivalis; SG, S
gordonii; SG-PG, pre-treatment with S
gordonii for 1 h followed by P gingivalis
stimulation for 6 h and 24 h.
44 J Med Genet 2011;48:38e47. doi:10.1136/jmg.2010.078998
Original article
group.bmj.com on November 25, 2014 - Published by http://jmg.bmj.com/Downloaded from 
inflammatory status of the gingiva. However, although healthy
gingival samples were taken from areas with no clinical signs of
inflammation, surfaces of the oral cavity are constantly exposed
to both commensal and pathogenic microorganisms. Therefore,
it can be speculated that the clinically healthy gingiva is
subjected to challenges similar to those of the early stages of
infection. Likewise, gingival samples with periodontitis repre-
sent a tissue where constant infection and chronic inflammation
occurred over years, and short term responses on the transcrip-
tional level are most likely missed in inflamed gingival tissue
samples. Here, an experimental setting that precisely controls
for pathogenic infection might be a better way to assess specific
transcriptional responses.
Because the functional variant(s) are as yet unknown for both
periodontitis as well as for CHD, we did not aim to study the
putative biological effects of the associated variants. Thus, we
did not distinguish between the allelic background in our cell
cultures, but studied the transcription pattern of the selected
genes in response to bacterial infection. We observed that after
24 h of stimulation of healthy HGFs and GECs with the path-
ogenic bacterium P gingivalis, CDKN2BAS was significantly
upregulated compared to the unstimulated controls. This real-
time response of CDKN2BAS gene activity to a specific patho-
genic inflammatory trigger indicates that CDKN2BAS is
subjected to pathogen sensitive transcriptional regulation.
Furthermore, the clear response after 24 h of stimulation, but
the absence of elevated transcript levels after 6 h of stimulation,
suggests that CDKN2BAS may be located at a downstream
position of a putative pathogen sensitive signalling cascade. We
further observed a minor but significant downregulation of
CDKN2A after 24 h of bacterial stimulation in both gingival
epidermal tissue and gingival fibroblasts. These large quantita-
tive differences in CDKN2BAS and CDKN2A transcript levels in
response to 24 h bacterial stimulation possibly indicate that
CDKN2A, unlike CDKN2BAS, is not directly regulated by
bacterial infection on the transcriptional level, but at a later
stage of this signal transduction cascade.
Our observations were in accordance with a very recent study
on CDKN2BAS function which showed that CDKN2BAS tran-
scripts negatively regulate CDKN2A expression.31 This recent
study detected that CDKN2BAS transcript initiates in prostate
cancer tissues at a start site several hundred bases upstream of the
previously reported start site. An antisense construct designed to
target this newly identified transcript caused a pronounced
increase in the expression of CDKN2A, but had a much less
profound effect onCDKN2B.31 In conjunction with various other
experiments, the authors concluded that the transcript encoded
upstream of the previously reported start site of CDKN2BAS
controlsCDKN2A silencing by cis recruitment of polycomb group
complex proteins, and in addition functions as an architectural
matrix to retain these proteins at the target site. Interestingly,
a recent study,which performed genomewide expression profiling
Figure 4 mRNA levels of CDKN2BAS,
CDKN2A, CDKN2B and CDK4 in human
gingival fibroblasts after stimulation
with Streptococcus gordonii and
Porphyromonas gingivalis. (A)
CDKN2BAS mRNA levels were
significantly increased in non-S gordonii
pre-treated (p¼0.004) and S gordonii
pre-treated human gingival fibroblasts
(HGFs) (p¼0.003) after 24 h of
stimulation with P gingivalis. (B)
CDKN2A mRNA levels were
significantly reduced in S gordonii pre-
treated and 24 h P gingivalis stimulated
HGFs compared to unstimulated HGFs
(p<0.001). (C, D) No significant
differences of mRNA levels were
observed for CDKN2B and CDK4 mRNA
levels in either condition. Each box plot
represents values derived from nine
independent experiments and cells from
three different donors were tested. C,
unstimulated cells; HGF, human gingival
fibroblasts; MPG, blank medium for P
gingivalis; MSG, blank medium for S
gordonii; PG, P gingivalis; SG, S
gordonii; SG-PG, pre-treatment with S
gordonii for 1 h followed by P gingivalis
stimulation for 6 h and 24 h.
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in healthy individuals who were homozygous for the common
and the rare allele of rs1333049, showed that the nature of the
genes and pathways linked to CDKN2BAS transcript levels
comprised genes which control cellular proliferation.30 These
studies did not functionally analyse exons 1e19, but a second
antisense construct designed to target exon 3 silencedCDKN2A to
a much lesser extent than the antisense construct upstream of
exon 1.31 Although the function of this transcriptwas not studied
in detail, it indicates that different CDKN2BAS transcripts may
have different functions. Currently, 10 alternative spliced variants
were reported in different tissues as diverse as lung, brain, heart,
vascular epithelial tissues, testis, and blood.30 45 46 Theymay have
specific functions in their tissue specific context, additional or
alternative to the observed negative control of CDKN2A. Two
studies measured the expression of CDKN2BAS spliced transcript
NR_003529, spanning exons 17 to 18, and found slightly decreased
expression which was associated with the risk allele in healthy
individuals.30 32
A study on individuals with clinically suspected CHD revealed
that NR_003529 expression was significantly increased in indi-
viduals with atherosclerotic plaque burden, and correlated ANRIL
transcript levels with severity of atherosclerosis.47 Our primers
for the quantification of CDKN2BAS transcript levels were
designed to detect NR_003529 transcripts, and we found
NR_003529 upregulation by bacterial infection. The correlation of
CDKN2BAS expression with bacterial infection and increased
CDKN2BAS expression in individuals with atherosclerotic plaque
burden add to the theory of inflammatory components in the
pathophysiology of CHD. Considering the recent finding on the
ability of the 59 transcript of CDKN2BAS to recruit and retain
regulatory proteins, the functions of the proximal and consider-
ably long sequences of CDKN2BAS might well have a similar
mechanistic function, but may also be able to act in trans.
Theories concerning the actual disease mechanism that is
mediated by the causative risk variants of CDKN2BAS remain
speculative, as the exact nature of the causative variants and the
target proteins or genes await elucidation. They possibly differ
between CHD and periodontitis. Here, we present findings
which link the pathogenicity of P gingivalis and its contribution
to rapid periodontal degradation to a biological mechanism that
is mediated by CDKN2BAS, that may directly act in cis on the
negative regulation of CDKN2A and the downstream lying
genes of the CDKN2A regulation cascade; or additionally, may
act on other, as yet unknown, trans-acting regulatory proteins
with unidentified genetic targets. Taking into consideration the
correlation of increased ANRIL transcript levels with the severity
of atherosclerosis,52 this link might also join bacterial infection
to atherosclerotic plaque burden by a potentially regulatory
mechanism that is mediated by ANRIL transcription.
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